Jane Hsiao, PhD

OPKO Health, Inc.
Miami, Florida, United States

Disclosure information not submitted.

Presentation(s):

• SAT-677 - EB618, First-in-Class Oral Tablet of Dual GLP-1/Glucagon Receptor Agonist for Patients with Obesity and Metabolic Disorders: Results from PK-PD Study in Non-Human Primates

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT